• Thermography Studies

  • Breast Screening Facts

  • 5 Most Important Early Detection Tests

October Specials:
Our Lowest Pricing of the Year!​
*Select locations
  • Breast Region:  $150 (reg. $175) *new clients only
  • Breast & Abdomen:  $250 (reg. $275)
  • Full Body:  $375 (reg. $475)

Questions about the validity of Thermography? Read this information!

Infrared Imaging of the Breast — An Overview

Over 40 years of research and 800 indexed papers encompassing well over 300,000 women participants has demonstrated infrared imaging’s abilities in the early detection of breast cancer. Infrared imaging has distinguished itself as the earliest detection technology for breast cancer. It has the ability to signal an alarm that a cancer may be forming up to 10 years before any other procedure can detect it.

In 7 out of 10 cases, infrared imaging will detect signs of a cancer before it is seen on a mammogram. Clinical trials have also shown that infrared imaging significantly augments the long-term survival rates of its recipients by as much as 61%. And when used as part of a multimodal approach (clinical examination, mammography, and infrared imaging) 95% of all early stage cancers will be detected. Ongoing research into the thermal characteristics of breast pathologies will continue to investigate the relationships between neoangiogenesis, chemical mediators, and the neoplastic process.

It is unfortunate, but many clinicians still hesitate to consider infrared imaging as a useful tool in spite of the considerable research database, steady improvements in both infrared technology and image analysis, and continued efforts on the part of the infrared imaging societies. This attitude may be due in part to the average clinician’s unfamiliarity with the physical and biological basis of infrared imaging. The other methods of cancer investigations refer directly to topics of medical teaching. For instance, radiography and ultrasonography refer to structural anatomy. Infrared imaging, however, is based on thermodynamics and thermokinetics, which are unfamiliar to most clinicians; though man is experiencing heat production and exchange in every situation he undergoes or creates.

Considering the contribution that infrared imaging has demonstrated thus far in the field of early breast cancer detection, all possibilities should be considered for promoting further technical, biological, and clinical research along with the incorporation of the technology into common clinical use.

• In 1982, the FDA approved breast thermography as an adjunctive breast cancer screening procedure.

• Breast thermography has undergone extensive research since the late 1950's.

• The numbers of participants in many studies are very large -- 10K, 37K, 60K, 85K

• Some of these studies have followed patients up to 12 years.

• Strict standardized interpretation protocols have been established for over 15 years.

• Breast thermography has an average sensitivity and specificity of 90%.

• An abnormal thermogram is 10 times more significant as a future risk indicator for breast cancer than a first order family history of the disease.

• A persistent abnormal thermogram caries with it a 22x higher risk of future breast cancer.

• An abnormal infrared image is the single most important marker of high risk for developing breast cancer.

• Breast thermography has the ability to detect the first signs that a cancer may be forming up to 10 years before any other procedure can detect it.

Read the full article

© 2020 by Mobile Thermographic Imaging. All rights reserved.

Disclaimer: Breast thermography is not a replacement or alternative for mammography or any other form of breast imaging. Breast thermography is meant to be used in addition to mammography and other tests. Breast thermography and mammography are complementary procedures, one does not replace the other. All thermography reports are meant to identify thermal emissions that suggest potential risk markers only and do not in any way suggest diagnosis and/or treatment. No breast screening is 100% accurate. The information provided in or through this website is not intended to be a substitute for professional medical advice, diagnosis or treatment provided by your own Medical Provider. Mobile Thermographic Imaging has no liability to any person or entity for any adverse consequence alleged to have happened directly or indirectly as a consequence of this material. The information provided in or through this website is for educational and informational purposes only. Telethermography systems are FDA regulated as a medical device under 21 CFR 884.2980. Telethermographic systems are intended as an adjunctive diagnostic screening

  • b-facebook